Techorizon is an advanced technologies services provider supporting the Pharmaceutical, Medical Devices and Biotechnology Industry supplying advanced solutions and services integrating people, processes and technology.
As the Technology subsidiary of CROMSOURCE, an International CRO, Techorizon is able to draw on its parent Company’s wealth of hands-on Clinical expertise and apply it to its massive investment in technology.
Techorizon is a company born from the experience gained through Research and continuous Information Technology application conception, design and development in the Pharma and Medical Industry World, to provide, through its services, affordable and high performance solutions to its Customers.
In February 2011, the Company achieved the ISO Certification 9001:2008 considering such accreditation as the basis of the company.
Quality management and quality assurance are kept under constant review and are assiduously implemented. The quality system is revised quarterly and thoroughly reviewed once a year by an external and independent Auditor.
As a services provider of the Pharmaceutical Companies and the consciousness of the importance of data integrity and data quality in the pharmaceutical environment, led Techorizon to decide to merge the common process of the software lifecycle with the principles of the Validation according to the FDA Guidelines and GAMP 5.
The Validation principles are the following: ”Establishing documented evidence which provides a high degree of assurance that a specific process will consistently produce a product, meeting its pre-determined specifications and quality attributes”
This global quality approach is what distinguishes Techorizon from the other IT companies.
Clin-Track® is a CROMSOURCE modular solution united in a single platform which allows total management of your clinical trial in real time. It is capable of collecting and presenting 360 degrees of information from a clinical trial, from central laboratories to electronic CRFs to single patient's diaries. Through this, the sponsor has immediate access to data on all phases of their clinical trial.